...
首页> 外文期刊>Journal of Clinical Microbiology >Evaluation of StrepBSelect Chromogenic Medium and the Fast-Track Diagnostics Group B Streptococcus (GBS) Real-Time PCR Assay Compared to Routine Culture for Detection of GBS during Antepartum Screening
【24h】

Evaluation of StrepBSelect Chromogenic Medium and the Fast-Track Diagnostics Group B Streptococcus (GBS) Real-Time PCR Assay Compared to Routine Culture for Detection of GBS during Antepartum Screening

机译:评估StrepBSelect发色培养基和快速诊断B组链球菌(GBS)实时PCR分析与常规培养相比,在产前筛查中检测GBS

获取原文
           

摘要

Group B streptococcus (GBS) is the most common cause of early-onset neonatal sepsis in developed countries (1, 2). Early-onset disease (0 to 6 days of life) is acquired intrapartum from mothers with vaginal-rectal colonization with GBS (1–3). Maternal GBS colonization rates range from approximately 10 to 40% in developed countries, with an estimated rate of 20% in near-term pregnant women in our health care region (2, 4, 5). Studies have shown that intrapartum administration of antibiotics reduces neonatal transmission of GBS, thereby preventing early-onset disease (1, 6, 7). Laboratory detection of GBS colonization status in near-term pregnant women is therefore important for the selective prescription of antibiotic prophylaxis at delivery.
机译:B组链球菌(GBS)是发达国家中早发性新生儿败血症的最常见原因(1、2)。早产疾病(0至6天的生命)是在阴道内经GBS定殖的母亲的产后获得的(1-3)。在发达国家,母亲GBS的定殖率大约为10%至40%,在我们的医疗保健地区,近期孕妇的估计率为20%(2、4、5)。研究表明,分娩期使用抗生素可以减少新生儿GBS的传播,从而预防早发疾病(1、6、7)。因此,实验室检测近期孕妇的GBS定植状态对于分娩时抗生素预防的选择性处方很重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号